Article Versions Notes

Tseng C-W, Liu W-C, Ko P-H, Chen Y-C, Tseng K-C, Chang T-T. The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients. Viruses. 2022; 14(8):1812. https://doi.org/10.3390/v14081812

Tseng, Chih-Wei, Wen-Chun Liu, Ping-Hung Ko, Yen-Chun Chen, Kuo-Chih Tseng, and Ting-Tsung Chang. 2022. "The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients" Viruses 14, no. 8: 1812. https://doi.org/10.3390/v14081812

Tseng, C. -W., Liu, W. -C., Ko, P. -H., Chen, Y. -C., Tseng, K. -C., & Chang, T. -T. (2022). The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients. Viruses, 14(8), 1812. https://doi.org/10.3390/v14081812